• Boeing (NYSE:BA) surpasses Airbus in jet orders for the first time since 2018.
• Delta Air Lines places its first direct order for Boeing 787 Dreamliners.
• Ethiopian Airlines commits to a 20 aircraft order with Boeing.
• Boeing advances a technology partnership with Salient Motion aimed at shortening certification cycles and lowering manufacturing costs.

Boeing, one of the two major global commercial jet manufacturers, is back in the spotlight as it overtakes Airbus in net orders for the first time in seven years. The combination of strong order activity and high profile airline commitments is putting renewed attention on how the company is positioned within commercial aviation and related services. For investors, NYSE:BA now sits at the center of several key industry conversations, including fleet renewal, production capacity, and the competitive dynamics of large commercial jets.

The new Salient Motion collaboration, focused on faster certification and more efficient manufacturing, highlights potential changes in how quickly new aircraft technologies move through regulatory and production pipelines. The progress of these efforts may have implications for Boeing's cost structure and development timelines, as well as its ability to adapt to airline demand cycles. Investors are likely to track how these contracts and partnerships relate to order backlog composition, delivery performance, and the stability of long term aircraft programs.

Stay updated on the most important news stories for Boeing by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Boeing.

Boeing topping Airbus in 2025 net orders, backed by large 787 commitments from Delta and Ethiopian and 600 commercial aircraft delivered in the year, signals that airline customers are still willing to place long dated bets on its widebody and narrowbody franchises. For you as an investor, this cluster of orders and deliveries points to airlines using Boeing aircraft as core assets for long haul and regional growth, while the Salient Motion partnership targets the cost and certification bottlenecks that have weighed on timelines in the past.

Boeing Narrative, Turnaround Story Backed By Orders

For anyone following the Boeing turnaround story, this news feeds into the existing narrative that the company is trying to move from crisis management to consistent execution, as reflected in its sixth best order year ever with 1,075 net orders and a 6,130 plane backlog at the end of 2025. The combination of long haul 787 orders, 737 MAX commitments, and progress on production of both programs gives investors more concrete data points to test views that have framed Boeing as either a recovery story or a speculative turnaround.

Risks and Rewards To Keep In Mind

• Large widebody and narrowbody orders from Delta, Ethiopian and others support multi year visibility on Boeing's commercial backlog.
• Salient Motion's modular, faster to certify actuation systems could help reduce unit costs and shorten development cycles if integration proceeds as planned.
• Investors are still watching whether Boeing can convert backlog into timely deliveries while working within FAA production caps and ongoing certification processes for models like the 737 MAX 7 and MAX 10.
• The company has recently reported large losses and cash burn, so execution on production, quality and program margins remains a key pressure point for the turnaround thesis.

What To Watch Next

From here, you may want to track whether quarterly deliveries for the 737 and 787 lines stay aligned with this order momentum, and how quickly cost and certification benefits from the Salient Motion platform show up in program commentary. If you want to see how other investors are framing this turnaround story and where they agree or disagree, you can compare different community narratives on Boeing for additional context.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.